📞 
— free, 24/7
— free, 24/7 — free, 24/7| Dosage | Package | Price per Dose | Price | |
|---|---|---|---|---|
| 15g | 12 tubes | £29.15 | £466.65 £349.99 Best Price Popular | |
| 15g | 6 tubes | £31.40 | £250.58 £187.93 | |
| 15g | 4 tubes | £32.52 | £174.05 £130.54 | |
| 15g | 2 tubes | £33.65 | £90.02 £67.51 |
Disclaimer: This information is for general guidance only and may not cover every situation. Always follow your healthcare professional’s advice and check the official patient information leaflet that accompanies etrivex (clobetasol). This page is intended for UK readers and may not reflect all local rules about prescription status.
Etrivex is a topical preparation that contains clobetasol propionate, a very potent corticosteroid. It is used to treat certain inflammatory skin conditions that have not responded to milder medicines. The clobetasol component works by dampening the body’s immune response in the skin, which helps reduce redness, swelling, itching and irritation.
The product is applied to the skin only. It is not meant for ingestion or for use on internal areas. Avoid contact with the eyes, mouth and inner nose. If accidental exposure occurs, rinse well with water and seek advice from a healthcare professional if you have concerns.
Etrivex may require a prescription depending on local rules. Your doctor, pharmacist or another healthcare professional can confirm whether this medicine is appropriate for you and explain how to use it safely. Do not use someone else’s medication or a product intended for another person’s skin condition.
Keep etrivex out of reach of children and pets. Do not use after the expiry date or if the packaging is damaged. If you notice any unusual symptoms after starting treatment, contact a healthcare professional promptly so they can reassess your treatment plan.
Because etrivex is a potent corticosteroid, it should be used only for the shortest time necessary and only on the areas of skin prescribed by your clinician. If you have any questions about how this medicine works or whether it is suitable for you, ask your pharmacist or doctor for clarification.
Etrivex is used to treat certain inflammatory and itchy skin conditions. It is particularly considered for severe or widespread symptoms where milder creams have not provided adequate relief. Conditions treated with clobetasol-containing preparations are usually identified by a clinician based on their appearance and the pattern of symptoms.
The medicine is applied to the affected skin areas only. It should not be used on large areas of the body unless a clinician has explicitly advised it, because higher absorption can occur with larger surfaces or with occlusive dressings. Do not use it on broken skin unless instructed by a professional, and avoid applying to mucous membranes unless directed.
Stability of the skin barrier plays a role in how well the medicine works. In some cases, clinicians may switch to milder therapies as the skin improves, to minimise potential side effects. If your condition changes or worsens while using etrivex, contact your healthcare professional for advice.
If you are unclear about whether etrivex is suitable for your specific skin condition, or if you have a suspected skin infection, seek advice from a pharmacist or doctor. They can help differentiate between inflammatory conditions and infections that may require different treatment approaches.
Clobetasol propionate is a corticosteroid. It reduces inflammation by suppressing the immune system’s response in the skin. This helps lower redness, swelling, itching and irritation associated with many inflammatory skin disorders.
Because it is a strong medication, its anti-inflammatory effect can be more pronounced than milder steroids. The intensity of the response depends on factors such as the thickness of the skin, the area being treated and how the skin absorbs the medicine. That is one reason why it should be used under medical supervision and for a limited period.
Topical corticosteroids can also affect the skin’s natural balance when used for a long time or on large areas. Your clinician will weigh the benefits against potential risks and advise on the shortest effective treatment duration. If you notice signs of thinning skin, stretch marks, or a change in skin colour, report these to a healthcare professional.
In addition to reducing symptoms, clobetasol may lead to temporary suppression of the local immune response. This is usually mild and transient when used as prescribed, but it is a reason for careful monitoring in certain patients, especially children and those with conditions requiring long-term treatment.
Overall, etrivex works by calming inflamed skin; however, it is not a cure. Ongoing skin care and adherence to the prescribed regimen help achieve the best balance between symptom control and safety. Always discuss any concerns about how the medicine is working with your clinician.
Use etrivex exactly as prescribed by your clinician. The usual approach is to apply a thin layer to the affected skin area once daily, or as directed. Do not apply a thick layer, and avoid applying to large areas unless advised. A small amount is typically sufficient to cover the affected region.
Before applying, wash your hands and ensure the skin is clean and dry. Apply only to intact skin unless your clinician has said otherwise. Do not apply to mucous membranes, eyes or mouth. If the medicine accidentally enters the eyes, rinse with plenty of water and seek medical advice if irritation persists.
Wash your hands after applying etrivex, unless you are treating your hands. If treatment is on the hands, follow your clinician’s guidance about washing and drying after application. Do not cover treated areas with tight bandages or occlusive dressings unless instructed, as this can increase absorption and the risk of side effects.
If you miss a dose, apply it as soon as you remember, unless it is almost time for your next dose. Do not double the dose to make up for a missed one. If you are unsure what to do, contact your pharmacist for guidance. Do not change the frequency or duration without medical advice.
Typical storage advice is to keep etrivex in a cool, dry place away from direct heat or sunlight. Return any unused medicine to the pharmacist if you are stopping treatment or if the product has passed its expiry date. Do not share your medicine with others, even if their symptoms look similar.
Etrivex should not be used by people who are allergic to clobetasol or any other ingredient in the product. If you have a history of allergic reactions to corticosteroids, tell your clinician before starting treatment.
Do not use etrivex on fungal skin infections unless your clinician confirms it is appropriate. Corticosteroids can worsen some infections if used alone. Similarly, avoid use on viral infections of the skin, such as herpes simplex, varicella, or chickenpox lesions, unless advised by a clinician.
It may not be suitable for use on the face, groin, or armpits unless the clinician has explicitly indicated this. Large-area use or prolonged courses may increase absorption and the risk of systemic effects, especially in children or in people with underlying medical conditions. If you have skin diseases such as dermatitis around the eyes or near mucous membranes, discuss this with your clinician before starting treatment.
Pregnant or breastfeeding people should use this medication only if clearly needed and after discussing potential risks with a clinician. Your doctor may adjust the treatment plan during pregnancy or lactation to balance benefits and safety for the baby and mother.
Because etrivex is a potent steroid, there is potential for thinning of the skin, changes in texture, and other local skin effects if used for a long time or on sensitive areas. Your clinician will monitor you for these effects and adjust treatment if needed.
Systemic absorption can occur, particularly when used over large areas, under occlusion, on damaged skin or in children. This means that some of the medicine can enter the bloodstream and cause side effects such as suppression of the body’s natural hormones. Long-term use should be avoided unless supervised by a clinician.
Be cautious when applying near the eyes. If an area near the eye is treated, monitor for irritation, blurred vision, or other eye symptoms. If you experience these, contact a healthcare professional promptly.
Tell your clinician about all medicines you use, including those bought over the counter, as well as any creams, ointments or sprays used on the skin. Some products may interact or alter absorption. If you are pregnant, planning a pregnancy, or breastfeeding, discuss treatment options and safety with your clinician before starting etrivex.
Like all medicines, etrivex can cause side effects in some people. Not everyone will experience them. Most side effects are mild and improve with continued use or after stopping the medicine.
If you notice any severe or persistent side effects, stop using the medicine and contact a healthcare professional promptly. Seek urgent medical help if you experience signs of a severe allergic reaction such as widespread swelling, severe rash, or difficulty breathing.
Some people may experience skin colour changes or hair growth in the treated area after stopping therapy. These effects are usually reversible after stopping treatment, but you should discuss any concerns with your clinician if they occur.
Most interactions involve other topical products used on the same area of skin. If you apply other creams, ointments, or medicated patches, do not mix them on the same area unless advised by a clinician. The presence of other skin conditions or infections can also affect how etrivex works.
Tell your clinician about any medicines you are taking for other conditions, including non-prescription products, as some medicines can affect how the skin responds to treatment. If you notice unexpected effects after starting etrivex, report them to your pharmacist or doctor for guidance.
If you are taking medications that affect the immune system or hormones, discuss this with your clinician. They can help determine whether etrivex is appropriate and how to monitor potential interactions.
Do not apply etrivex to infected skin without medical advice, as infections may require different treatment and could be worsened by improper use of corticosteroids.
Pregnant or breastfeeding people should use etrivex only if clearly needed and after a careful discussion with a clinician. The decision will consider the potential benefits to the mother and any possible risks to the baby.
If you become pregnant while using etrivex, contact your clinician promptly. They can advise on whether to continue treatment, adjust the regimen, or switch to a safer alternative for the pregnancy period.
Adults who are breastfeeding should use the product only on areas of the skin that are not in contact with the baby’s mouth or digestive tract. If you need to treat the chest or nipple area while breastfeeding, discuss this with your clinician to minimise exposure to the infant.
For any person who is planning to conceive, or who is currently pregnant or breastfeeding, consult a healthcare professional before starting or continuing treatment with etrivex. They can provide personalised guidance based on your condition and treatment goals.
Many people notice some improvement within a few days, but the full effect may take longer depending on the condition and area of skin being treated. Your clinician will provide guidance on what to expect and when to reassess the treatment.
If you forget a dose, apply it when you remember unless it is nearly time for your next dose. Do not double the dose. If you are unsure what to do, contact your pharmacist for advice.
You can use other skin products, but avoid applying them at the same time as etrivex on the same area unless advised by your clinician. Some products can irritate the skin or affect absorption.
Seek medical advice if your condition worsens, if you develop signs of infection, if you notice thinning skin, or if you are unable to reduce your symptoms with the prescribed regimen. If you have severe reactions or symptoms such as swelling of the face or difficulty breathing, seek urgent medical help.
Topical corticosteroids like clobetasol can be more risky on the face due to thinner skin. Use on the face should only occur if explicitly advised by a clinician, and treatment duration should be limited. If facial use is prescribed, follow the clinician’s instructions closely.
Children absorb topical medicines more easily, so doctors may choose different regimens and monitor closely. If a clinician prescribes etrivex for a child, follow their dosing and duration instructions carefully and report any concerns such as skin changes or growth-related effects.
Signs of an allergy can include severe itching, swelling, rash, or trouble breathing. If this happens, stop using the product and seek urgent medical help or contact a healthcare professional promptly.
Do not stop suddenly without discussing with your clinician. Some conditions may flare if treatment is stopped abruptly. Your clinician can guide you on the safest way to discontinue or taper use if needed.
Topical steroids do not typically interact with vaccines, but sun exposure and certain skin products can affect healing and irritation. Protect treated skin from excessive sun exposure and use sunscreen as advised by your clinician if recommended. If you have any concerns about vaccine timing or skin care during treatment, ask your pharmacist or doctor.
If symptoms return after stopping treatment, contact your clinician. They may decide to restart a therapy or switch you to a milder regimen to control symptoms and minimise side effects.
This information reflects general patient guidance and is intended to support conversations with healthcare professionals. For specific details about etrivex, refer to the official patient information leaflet supplied with the medicine and discuss any questions with your pharmacist or clinician. Your local healthcare provider can offer personalised advice based on your medical history and current treatments.
Possible sources for further reading include official patient information leaflets and authorised medicines information provided by manufacturers, as well as national guidance from approved health authorities. Always verify with a healthcare professional if you are unsure about any aspect of your treatment.
14–21 days. Free from £150.05 .
5–9 days. £22.51
−10% when paying with cryptocurrency.
−10% on all repeat orders.
All orders are packed in neutral, unbranded boxes with no product name on the outside.